SFM
PFE icon

Sphera Funds Management’s Pfizer PFE Stock Holding History

Sphera Funds Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,108
Closed -$82K – 117
2014
Q1 		$82K Sell
2,108
-685,205
-100% -$20.4M 0.02% 110
2013
Q4 		$20M Buy
+687,313
New +$20M 5.56% 4

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sphera Funds Management's PFE Position: Q1 2026 in Review

Sphera Funds Management increased its Pfizer (PFE) stake by 116% in Q1 2026, buying an estimated $2.66M and bringing the position to 186,000 shares worth $5.22M. The position accounts for 0.83% of the portfolio, ranked #45.

Sphera Funds Management first reported a position in PFE in Q4 2013 and has held it in 35 quarters since. The position peaked at $47.6M in Q3 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sphera Funds Management held 186,000 shares of Pfizer worth $5.22M as of Q1 2026.
  • Sphera Funds Management bought 100,000 Pfizer shares in Q1 2026, an estimated $2.66M.
  • Pfizer made up 0.83% of Sphera Funds Management's portfolio in Q1 2026, its #45 holding.
  • Sphera Funds Management first reported a position in Pfizer in Q4 2013 and has held it in 35 quarters since.
  • Sphera Funds Management's Pfizer position peaked at $47.6M in Q3 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.